Astrana Health, Inc. provided earnings guidance for the year ending December 31, 2024. For the year, the company expects total revenue in the range of $1,650.0 million to $1,850.0 million, Net income attributable to Astrana Health, Inc. in the range of $61.0 million to $73.0 million and EPS ? diluted in the range of $1.28 to $1.52.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.3 USD | -1.45% | +2.32% | +4.60% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.60% | 2B | |
+19.18% | 84.56B | |
-27.01% | 72.41B | |
+2.04% | 27.73B | |
-8.09% | 17.75B | |
-1.10% | 17.11B | |
+5.31% | 16.03B | |
+71.98% | 13.07B | |
+6.32% | 12.91B | |
+70.39% | 12.55B |
- Stock Market
- Equities
- ASTH Stock
- News Astrana Health, Inc.
- Astrana Health, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024